11/17/2008
Palatin Technologies, Inc. Reports Fiscal Year 2009 First Quarter Results; Teleconference and Webcast To Be Held on ... (PR Newswire via Yahoo! Finance)
Palatin Technologies, Inc. announced today results for its first quarter ended September 30, 2008.
MORE INFO
|
11/13/2008
Palatin Technologies to Report Fiscal Year 2009 First Quarter Results; Conference Call and Webcast on November 17, 2008 (PR Newswire via Yahoo! Finance)
Palatin Technologies, Inc. will announce its first quarter, fiscal year 2009 financial results on Monday, November 17, 2008 before the open of the U.S. financial markets.
MORE INFO
|
11/10/2008
BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update (CNW Group via Yahoo! Finance)
BELLUS Health Inc. reports results for the third quarter ended September 30, 2008. For the three-month period ended September 30, 2008, the net loss amounted to $11,095,000 , compared to $13,889,000 for the corresponding period the previous year.
MORE INFO
|
11/08/2008
Greeley firm's product recalled, lacks FDA approval (Greeley Tribune)
A product once marketed by a Greeley firm as a device that could treat medical problems such as cancer and depression has been recalled because the device has not been approved by the Food and Drug Administration, lacks safety and effectiveness data...
MORE INFO
|
11/01/2008
Polyphor signs licensing agreement with Allergan (Pharmaceutical Business Review)
Swiss biotech company Polyphor has entered into an exclusive worldwide discovery and licensing agreement with Allergan, a multi-specialty healthcare company, under which Allergan obtains the rights to develop protein epitope mimetics cytokine inhibitors for the treatment of conditions and diseases of the eye.
MORE INFO
|
11/06/2008
SkinMedica Launches TNS Essential Serum(TM) (PR Newswire via Yahoo! Finance)
SkinMedica, Inc., today announced the recent launch of TNS Essential Serum a revolutionary anti-aging treatment with a clinically-proven combination of two cutting-edge treatments, TNS Recovery Complex® and APS Corrective Complex.
MORE INFO
|
10/31/2008
Polyphor to Enter into an Exclusive Agreement with Allergan for the Development of Protein Epitope Mimetics (PEM) ... (Centre Daily Times)
Polyphor Ltd today announced that it has entered into an exclusive worldwide discovery and license agreement with Allergan, Inc., under which Allergan obtains the rights to develop PEM cytokine inhibitors for the treatment of conditions and diseases of the eye.
MORE INFO
|
11/05/2008
International Society for Stem Cell Research Applauds Outcome of Proposal 2 Advancing Stem Cell Research (PR Newswire via Yahoo! Finance)
On Tuesday, Michigan voters were asked to support Michigan's Proposal 2, a state initiative to accelerate medical research and develop new stem cell treatments for currently incurable diseases.
MORE INFO
|
11/03/2008
New Method Provides Panoramic View Of Protein-RNA Interactions In Living Cells (Medical News Today)
DNA, it has turned out, isn't all it was cracked up to be. In recent years we learned that the molecule of life, the discovery of the 20th century, did not -- could not -- by itself explain the huge differences in complexity between a human and a worm. Forced to look elsewhere, scientists turned to RNA, a direct yet more complex transcript of DNA.
MORE INFO
|
11/02/2008
New Method Provides Panoramic View Of Protein-RNA Interactions In Living Cells (Science Daily)
Scientists have developed a genome-wide platform to study how specialized proteins regulate RNA in living, intact cells. The platform allows researchers to identify, in a single experiment, every sequence within every strand of RNA to which proteins bind. The result is an unbiased and unprecedented look at how differences in RNA can explain how a worm and a human can each have 25,000 genes yet ...
MORE INFO
|